BCAAs : Muscle Preservation During Weight Loss
B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。Systematic review of 36 studies found BCAA supplementation during caloric restriction preserved lean body mass better than restriction alone. Observational study (n=4,429) found inverse association between BCAA intake and obesity (OR 0.66). Benefits are most pronounced when total protein intake is inadequate.
結論
Systematic review of 36 studies found BCAA supplementation during caloric restriction preserved lean body mass better than restriction alone. Observational study (n=4,429) found inverse association between BCAA intake and obesity (OR 0.66). Benefits are most pronounced when total protein intake is inadequate.
Key Study Findings
対象集団: healthy subjects
Key Statistics
36
研究数
4000
参加者数
Positive
グレード
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- general:
- 5-10 g/day (2:1:1 leucine:isoleucine:valine)
- preexercise:
- 5-10 g
- musclepreservation:
- 10-20 g/day during caloric deficit
上限量: No established UL; 35 g/day used safely in clinical trials
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
推奨摂取タイミング: Pre- or intra-exercise; between meals during caloric restriction
Safety & Side Effects
報告されている副作用
- ⚠ Nausea (at high doses)
- ⚠ GI discomfort
- ⚠ Fatigue (very high doses)
既知の相互作用
- ● Diabetes medications (may affect blood sugar)
- ● Levodopa (competition for absorption)
- ● Diazoxide
耐容上限摂取量: No established UL; 35 g/day used safely in clinical trials
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does BCAAs help with Muscle Preservation During Weight Loss?
How much BCAAs should I take for Muscle Preservation During Weight Loss?
Are there side effects of BCAAs?
How strong is the evidence for BCAAs and Muscle Preservation During Weight Loss?
Related Evidence
に関する他の成分: Muscle Preservation During Weight Loss
References
- [1] Shi-Jun Yue et al.. Am J Physiol Endocrinol Metab. 2019. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. doi:10.1152/ajpendo.00256.2018 PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。